FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2966700863> ?p ?o ?g. }

• W2966700863 endingPage "107733" @default.
• W2966700863 startingPage "107733" @default.
• W2966700863 abstract "Cannabidiol and cannabidiol-enriched products have recently attracted much attention as an add-on therapy for epilepsy, especially drug-resistant seizures. It should be, however, remembered that concomitant use of cannabidiol and antiepileptic drugs may pose a risk of interactions between them. For this reason, the aim of our study was to assess the effect of cannabidiol on the activity of selected new antiepileptic drugs in the electrically-induced seizure models in mice. We studied the effect of cannabidiol on the anticonvulsant action of topiramate, oxcarbazepine, lamotrigine, and pregabalin in the maximal electroshock-induced seizure test as well as on the activity of levetiracetam, tiagabine, lacosamide, and gabapentin in the 6 Hz seizure test in mice. We showed that cannabidiol increased the activity of topiramate, oxcarbazepine, pregabalin, tiagabine, and gabapentin. It did not affect the anticonvulsant effect of lamotrigine and lacosamide. Interestingly, cannabidiol attenuated the anticonvulsant activity of levetiracetam. Co-administration of antiepileptic drugs with cannabidiol did not cause adverse effects such as impairment of motor coordination, changes in neuromuscular strength or potentiation of the cannabidiol-induced hypolocomotion. Serum and brain levels of antiepileptic drugs and cannabidiol were determined by using HPLC in order to ascertain any pharmacokinetic contribution to the observed behavioral effects. Only interaction with levetiracetam was purely pharmacodynamic in nature because no changes in serum and brain concentration of either levetiracetam or cannabidiol were observed. Increased anticonvulsant activity of topiramate, oxcarbazepine, pregabalin, tiagabine, and gabapentin could be, at least in part, related to pharmacokinetic interactions with cannabidiol because there were changes in serum and/or brain concentrations of antiepileptic drugs and/or cannabidiol. Pharmacokinetic interactions cannot be also excluded between lacosamide and cannabidiol because cannabidiol increased brain concentration of lacosamide and lacosamide increased brain concentration of cannabidiol. Further pharmacokinetic studies are required to evaluate the type of interactions between cannabidiol and novel antiepileptic drugs." @default.
• W2966700863 created "2019-08-13" @default.
• W2966700863 creator A5034537296 @default.
• W2966700863 creator A5036187783 @default.
• W2966700863 creator A5047884679 @default.
• W2966700863 creator A5055296585 @default.
• W2966700863 creator A5073818963 @default.
• W2966700863 date "2019-11-01" @default.
• W2966700863 modified "2023-10-11" @default.
• W2966700863 title "Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies" @default.
• W2966700863 cites W1176583637 @default.
• W2966700863 cites W1554576051 @default.
• W2966700863 cites W1837420347 @default.
• W2966700863 cites W1873975405 @default.
• W2966700863 cites W1984508693 @default.
• W2966700863 cites W1992296963 @default.
• W2966700863 cites W1997220879 @default.
• W2966700863 cites W2009317359 @default.
• W2966700863 cites W2011095043 @default.
• W2966700863 cites W2017398416 @default.
• W2966700863 cites W2035699174 @default.
• W2966700863 cites W2038905679 @default.
• W2966700863 cites W2041103585 @default.
• W2966700863 cites W2062246677 @default.
• W2966700863 cites W2065707424 @default.
• W2966700863 cites W2088811688 @default.
• W2966700863 cites W2091591494 @default.
• W2966700863 cites W2094374357 @default.
• W2966700863 cites W2096565553 @default.
• W2966700863 cites W2097530890 @default.
• W2966700863 cites W2099595170 @default.
• W2966700863 cites W2100283245 @default.
• W2966700863 cites W2100990673 @default.
• W2966700863 cites W2109321075 @default.
• W2966700863 cites W2122465097 @default.
• W2966700863 cites W2126814491 @default.
• W2966700863 cites W2129406235 @default.
• W2966700863 cites W2138313528 @default.
• W2966700863 cites W2160246128 @default.
• W2966700863 cites W2166464521 @default.
• W2966700863 cites W2227862270 @default.
• W2966700863 cites W2231780556 @default.
• W2966700863 cites W2258876093 @default.
• W2966700863 cites W2309274031 @default.
• W2966700863 cites W2315569879 @default.
• W2966700863 cites W2401156716 @default.
• W2966700863 cites W2414143586 @default.
• W2966700863 cites W2468108139 @default.
• W2966700863 cites W2493372935 @default.
• W2966700863 cites W2552107770 @default.
• W2966700863 cites W2568338767 @default.
• W2966700863 cites W2591427933 @default.
• W2966700863 cites W2592601290 @default.
• W2966700863 cites W2596231189 @default.
• W2966700863 cites W2610432544 @default.
• W2966700863 cites W2693016255 @default.
• W2966700863 cites W2744115661 @default.
• W2966700863 cites W2774662302 @default.
• W2966700863 cites W2781878766 @default.
• W2966700863 cites W2785059893 @default.
• W2966700863 cites W2791384105 @default.
• W2966700863 cites W2791398812 @default.
• W2966700863 cites W2804921146 @default.
• W2966700863 cites W2883754089 @default.
• W2966700863 cites W2891640176 @default.
• W2966700863 cites W2905603477 @default.
• W2966700863 cites W2907499793 @default.
• W2966700863 cites W2914333425 @default.
• W2966700863 cites W2979896320 @default.
• W2966700863 doi "https://doi.org/10.1016/j.neuropharm.2019.107733" @default.
• W2966700863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31377197" @default.
• W2966700863 hasPublicationYear "2019" @default.
• W2966700863 type Work @default.
• W2966700863 sameAs 2966700863 @default.
• W2966700863 citedByCount "23" @default.
• W2966700863 countsByYear W29667008632020 @default.
• W2966700863 countsByYear W29667008632021 @default.
• W2966700863 countsByYear W29667008632022 @default.
• W2966700863 countsByYear W29667008632023 @default.
• W2966700863 crossrefType "journal-article" @default.
• W2966700863 hasAuthorship W2966700863A5034537296 @default.
• W2966700863 hasAuthorship W2966700863A5036187783 @default.
• W2966700863 hasAuthorship W2966700863A5047884679 @default.
• W2966700863 hasAuthorship W2966700863A5055296585 @default.
• W2966700863 hasAuthorship W2966700863A5073818963 @default.
• W2966700863 hasConcept C112705442 @default.
• W2966700863 hasConcept C118552586 @default.
• W2966700863 hasConcept C126322002 @default.
• W2966700863 hasConcept C142724271 @default.
• W2966700863 hasConcept C170493617 @default.
• W2966700863 hasConcept C204787440 @default.
• W2966700863 hasConcept C2775858608 @default.
• W2966700863 hasConcept C2776468701 @default.
• W2966700863 hasConcept C2776608144 @default.
• W2966700863 hasConcept C2776749334 @default.
• W2966700863 hasConcept C2776895053 @default.
• W2966700863 hasConcept C2777056318 @default.
• W2966700863 hasConcept C2777138316 @default.

• next